Ayat G. Lashen

University Park
Nottingham, ENG NG73RD, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Clinicopathological and functional evaluation of replication protein A in epithelial ovarian cancers: A target validation study.

Clinicopathological and functional evaluation of replication protein A in epithelial ovarian cancers: A target validation study.

Journal: Translational oncology

Published: November 13, 2025

Clinicopathological Significance of Transcription Factor p73 in Breast Cancers: Protein Expression and Transcriptomic Study.

Clinicopathological Significance of Transcription Factor p73 in Breast Cancers: Protein Expression and Transcriptomic Study.

Journal: Biomedicines

Published: August 02, 2025

PRDX1 protects ATM from arsenite-induced proteotoxicity and maintains its stability during DNA damage signaling.

PRDX1 protects ATM from arsenite-induced proteotoxicity and maintains its stability during DNA damage signaling.

Journal: Oncotarget

Published: May 19, 2025

Investigation of ribociclib, abemaciclib and palbociclib resistance in ER+ breast cancer cells reveal potential therapeutic opportunities`.

Investigation of ribociclib, abemaciclib and palbociclib resistance in ER+ breast cancer cells reveal potential therapeutic opportunities`.

Journal: Scientific reports

Published: January 17, 2025

Transcription Factor p73 Is a Predictor of Platinum Resistance and Promotes Aggressive Epithelial Ovarian Cancers.

Transcription Factor p73 Is a Predictor of Platinum Resistance and Promotes Aggressive Epithelial Ovarian Cancers.

Journal: International journal of molecular sciences

Published: January 07, 2025

Hydroxyacid Oxidase 1, a Glutamine Metabolism-Associated Protein, Predicts Poor Patient Outcome in Luminal Breast Cancer.

Hydroxyacid Oxidase 1, a Glutamine Metabolism-Associated Protein, Predicts Poor Patient Outcome in Luminal Breast Cancer.

Journal: International journal of molecular sciences

Published: September 25, 2024

Characterization of Breast Cancer Intra-Tumor Heterogeneity Using Artificial Intelligence.

Characterization of Breast Cancer Intra-Tumor Heterogeneity Using Artificial Intelligence.

Journal: Cancers

Published: August 26, 2024

The Clinicopathological Significance of the Cyclin D1/E1-Cyclin-Dependent Kinase (CDK2/4/6)-Retinoblastoma (RB1/pRB1) Pathway in Epithelial Ovarian Cancers.

The Clinicopathological Significance of the Cyclin D1/E1-Cyclin-Dependent Kinase (CDK2/4/6)-Retinoblastoma (RB1/pRB1) Pathway in Epithelial Ovarian Cancers.

Journal: International journal of molecular sciences

Published: February 29, 2024

Clinicopathological Significance of Cyclin-Dependent Kinase 2 (CDK2) in Ductal Carcinoma In Situ and Early-Stage Invasive Breast Cancers.

Clinicopathological Significance of Cyclin-Dependent Kinase 2 (CDK2) in Ductal Carcinoma In Situ and Early-Stage Invasive Breast Cancers.

Journal: International journal of molecular sciences

Published: February 26, 2024

Nottingham prognostic x (NPx): a risk stratification tool in ER-positive HER2-negative breast cancer: a validation study.

Nottingham prognostic x (NPx): a risk stratification tool in ER-positive HER2-negative breast cancer: a validation study.

Journal: Histopathology

Published: December 28, 2023

Prognostic and Clinical Significance of the Proliferation Marker MCM7 in Breast Cancer.

Prognostic and Clinical Significance of the Proliferation Marker MCM7 in Breast Cancer.

Journal: Pathobiology : journal of immunopathology, molecular and cellular biology

Published: December 11, 2023

The characteristics and prognostic significance of histone H1 expression in breast cancer.

The characteristics and prognostic significance of histone H1 expression in breast cancer.

Journal: Pathology

Published: November 22, 2023

Showing 1-12 of 30

Last Updated: 09/26/2026